Tagged Articles

multi-district litigation 54 articles

Plaintiffs want information on cases of pancreatic cancer associated with type 2 diabetes drugs

A federal judge denied plaintiffs’ motion to gather drug companies’ analysis of pancreatic cancer cases among users of their type 2 diabetes drugs; however, his decision is still pending regarding plaintiffs’ request to gather adverse event reports involving those drugs submitted to the U.S. Food and Drug Administration (FDA). U.S. District Judge Anthony Battaglia is presiding over a multidistrict litigation (MDL) involving about 460 plaintiffs who allege they developed pancreatic cancer after taking one of four drugs in a class of type 2 diabetes drugs known as incretin mimetics. The lawsuits name Amylin Pharmaceuticals and Eli Lilly & Co., for the drug Byetta; Merck ... Read More

Lawsuits against Bayer alleging neurological side effects from Mirena IUD will not be centralized

Nine lawsuits against Bayer Healthcare Pharmaceuticals alleging the company’s Mirena IUD caused neurological conditions will not be consolidated into a multidistrict litigation because there are just too few to justify the motion. Plaintiffs had asked that the lawsuits be centralized in Tennessee; Bayer opposed centralization or to have them consolidated in New York. Bayer already faces multidistrict litigation with its Mirena intrauterine device over uterine perforation, a different injury. These nine lawsuits claim that the Mirena IUD contraceptive device releases a synthetic hormone that can cause neurological problems, including a type of brain damage known as pseudo tumor cerebra (PTC) ... Read More

Advocacy group calls for criminal investigation into destruction of documents in transvaginal mesh lawsuit

A consumer advocacy group is asking the U.S. Department of Justice  (DOJ) to investigate whether Johnson & Johnson purposely destroyed documents relevant to multidistrict litigation involving its transvaginal mesh device. Consumer Action Network, a nonprofit organization advocating for consumer and workers’ rights, pushed for the criminal investigation after a West Virginia judge last month found that Johnson & Johnson’s destruction or loss of documents was negligent but not deliberate. The nonprofit argues that the judge was only able to consider a portion of the evidence before making her decision. An attorney general would have a wider scope and the ability ... Read More

Forest to pay millions to Missouri parents for misleading drug data on childhood depression meds

Forest Laboratories will pay between $7.7 million and $10.4 million to settle multidistrict litigation alleging the drug company misled Missouri parents into buying Celexa and Lexapro for their children even though the antidepressants were not approved for children. The class includes all parents and other third parties in Missouri who purchased Celexa for a minor patient between Jan. 1, 1998, and Dec. 31, 2013, or Lexapro for a child between Aug. 1, 2002, and Dec. 31, 2013. Forest is accused of covering up clinical trial data that showed Celexa was ineffective in treating pediatric depression based on studies from as ... Read More

Jury should know Johnson & Johnson destroyed transvaginal mesh documents, U.S. judge says

A U.S. judge has found that Johnson & Johnson and its Ethicon unit destroyed company documents about some of its transvaginal mesh implants ahead of its Feb. 10 trial in which the health care conglomerate is defending itself against thousands of personal-injury lawsuits. U.S. magistrate judge Cheryl Eifert concluded that Ethicon destroyed thousands of computer files and other documents pertaining to its Gynecare Prolift and TVT Retropublic mesh devices, which thousands of women blame for excruciating internal injuries. Because the company acted improperly, juries may be allowed to hear and weigh evidence about the alleged document dumping, Judge Eifert said. ... Read More

Johnson and Johnson wants to conceal failure to preserve evidence in transvaginal mesh lawsuit

Johnson & Johnson is asking a West Virginia federal judge not to allow the plaintiff in an upcoming bellwether trial in multidistrict litigation over injuries caused by its transvaginal mesh to tell jurors that the company failed to preserve evidence. Johnson & Johnson claims the issue is no longer relevant to the case. U.S. Magistrate Judge Cheryl Eifert found the consumer health care giant had lost potential evidence in the case and suggested that jurors may need to hear about circumstances such as when a plaintiff’s physician relied on evidence provided by a sales representative whose records were destroyed. The ... Read More

New documentary to portray the severity of transvaginal mesh injuries

A new documentary film currently in production will feature a number of women from the U.S., Canada, and other countries whose bodies, and subsequently their lives, were devastated after being implanted with transvaginal mesh products designed to correct pelvic organ prolapse, urinary incontinence, and other conditions affecting the position of the pelvic organs. The documentary, called Enmeshed, is a collaboration between Philip Courter of Courter Films and Jane Akre, editor of the Mesh Medical Device News Desk, a watchdog group that monitors the medical mesh industry and the ways in which transvaginal mesh devices, hernia patches, and other polypropylene mesh ... Read More

Judge refuses to approve NFL’s multimillion dollar concussion settlement for retired players

A Pennsylvania federal judge has refused to approve a $760 million multidistrict litigation settlement agreement between the National Football League (NFL) and former players who sustained long-term injuries from concussions. U.S. District Judge Anita Brody said she was concerned that the league wasn’t putting up enough money to compensate all members in the class. The settlement is designed to resolve lawsuits from retired NFL players who alleged that the league did not do enough to protect players from concussions and other brain trauma nor did they do enough to address the long term risks of these injuries. The arrangement is designed ... Read More

Merck agrees to settle hundreds of Fosamax ONJ cases

Drug maker Merck & Co. has agreed to pay $27.7 million to settle about 1,200 federal and state lawsuits claiming its osteoporosis drug Fosamax caused users to develop a bone disease known as osteonecrosis of the jaw, or ONJ. The agreement comes just after U.S. District Judge John Keenan, frustrated over stalled settlement talks, ordered that 200 cases per month be moved out of the multidistrict litigation into home courts. The agreement is a long time coming. Since the litigation began in 2005, seven bellwether trials have been decided. Merck was hit with verdicts of $285,000 and $8 million, the ... Read More

Judge delays C.R. Bard transvaginal mesh trial amid settlement talks

A federal bellwether trial against transvaginal mesh maker C.R. Bard that was scheduled to start Dec. 3 has been pushed back to January 10, 2014. C.R. Bard is one of six transvaginal mesh manufacturers facing more than 30,000 personal injury lawsuits combined for multidistrict litigation (MDL) in a Charlestown, W.Va., federal court. The rescheduled case was filed on behalf of a woman who alleges she was seriously injured by a Bard Avaulta vaginal mesh implant. Her lawsuit is one of four cases against C.R. Bard selected for the first round of bellwether trials, which are intended to consolidate discovery and ... Read More